To improve immunotherapy, researchers look to shift immune cells' access to sugar
Cancer cells and immune cells share something in common: They both love sugar.
Feb 16, 2021
0
46
Cancer cells and immune cells share something in common: They both love sugar.
Feb 16, 2021
0
46
A large team of researchers affiliated with a host of institutions in the U.S., France and Spain has found that the drug plitidepsin worked better at treating COVID-19 than did remdesivir in a lab setting. In their paper ...
Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance to immune checkpoint blockade therapies in melanoma. It has revealed a central role for ...
Jan 12, 2021
0
42
A drug that has shown promise for treating multiple sclerosis may actually make the debilitating disease worse, new research from the University of Virginia School of Medicine suggests.
Nov 13, 2020
0
120
A team of biomedical engineers from Australia and Germany studied how human and mouse cells communicate with each other and found that this humanized tissue is physiologically integrated into single functional bone tissue ...
Nov 2, 2020
0
16
Neuropsychiatric illnesses like schizophrenia and autism are a complex interplay of brain chemicals, environment, and genetics that requires careful study to understand the root causes. Scientists have traditionally relied ...
Oct 1, 2020
0
118
Why do pregnancies last longer in some species than others? Researchers at the Francis Crick Institute have found the clock that sets the speed of embryonic development and discovered the mechanism is based on how proteins ...
Sep 17, 2020
0
203
An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline ...
Sep 3, 2020
0
193
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor's healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can ...
Aug 28, 2020
0
106
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Aug 27, 2020
0
100